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Bone marrow-derived (B) lymphocytes in man and mouse have characteristic cell 
surface markers, such as immunoglobulin,  that  distinguish  this subpopulation from 
other types of lymphocytes (1-4). In the mouse, thymus-derived (T) lymphoeytes also 
have cell  markers, such as theta antigen  (Thy  1.2)  and  Ly antigens,  that typify this 
cell type (5-7).  In contrast, human T-cell surface markers are not as well delineated. 
T  lymphocytes have receptors for and form rosettes with unsensitized sheep erythro- 
cytes  (SRBC) t  and  display  a  differentiation  marker,  human  T  lymphocyte antigen 
(HTLA) (8-10). The chemical nature of both the SRBC receptor and HTLA are not 
well defined. 
We have previously shown that  a  protein,  termed  macromolecular insoluble  cold 
globulin  (MICG), is an exclusive product ofT  cells in the mouse (11-13).  The name 
MICG has been used to describe the major physicochemical properties of this protein. 
It has a mol wt of 225,000 daltons, is insoluble in the cold in nonionic detergents, and 
migrates as a fl-globulin on electrophoresis. The present communication describes the 
characterization  of an  analogous  protein  in  human  T  cells,  termed  T-MICG.  We 
further  demonstrate  a  protein  in null  (N)  cells,  termed  N-MICG, which  has similar 
physical properties to, but differs antigenically from, T-MICG. 
Materials and Methods 
Isolation of Human Lymphocytes and Subpopulations.  Peripheral blood mononuclear cells (PBL) 
were separated  from  100  ml  of heparinized  whole blood  by Ficoll-Hypaque centrifugation 
(FHC) (14). The PBL were depleted of monocytes by adherence to plastic Petri dishes for 1 h 
at  37°C  (15).  Morphological examination of these cells  0Nright-Giemsa staining of smears) 
demonstrated a mean of 98% lymphocytes and 2% monocytes. They are subsequently referred 
to as lymphocytes. T  cells  in these preparations were enumerated  by rosette formation with 
SRBC and separated from PBL by rosette sedimentation (9,  16). Briefly, fresh SRBC (Grand 
Island Biological Co., Grand Island, N. Y.) are washed in phosphate-buffered saline (PBS) and 
resuspended to a concentration of 5% in Hanks' Balanced Salt Solution (HBSS) (Grand Island 
Biological Co.).  1 ml of neuraminidase  (Behring Diagnostics, Somerville, N. J.), diluted to 0.5 
U/ml in HBSS, is added to 1 ml of 5% SRBC. The mixture is incubated for 30 min at 37°C, 
i Abbreviations used in this paper." FHC, Ficoll-Hypaque centrifugation; FITC, fluorescein isothiocyanate; 
HBSS, Hanks'  balanced salt solution; HTLA, human  T  lymphocyte antigen;  MICG, macromolecular 
insoluble cold globulin; N, null; NP-40, Nonidet P-40; PAGE, polyacrylamide gel electrophoresis; PBL, 
peripheral blood mononuclear cells; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate; SRBC, 
sheep erythrocytes. 
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washed with RPMI-1640 (Grand Island Biological Co.), and diluted to 0.5% SRBC. To a 0.5- 
ml suspension of 0.5% SRBC is added 0.5 ml of a lymphocyte suspension containing 2  ×  106 
cells/ml. The mixture is incubated at 37°C for 15 rain, centrifuged at 200 g for 5 min at room 
temperature, and placed at 4°C for 60 rain. The tubes are then inverted and the cells stained 
with 0.5% toluidine blue and placed in a hemocytometer and 200 lymphocytes counted and 
expressed as the percent of E rosettes,  i.e., percent of iymphocytes forming rosettes  with SRBC 
(three or more). After PBL were rosetted with SRBC, the cell mixture was subjected to a second 
FHC. The pellet, containing free SRBC and E rosettes,  was incubated at 37°C for 15 min to 
dissociate the rosettes and then either hypotonically lysed in deionized water or subjected to 
another FHC. These cells are referred to as T-lymphocytes (E+). This subpopulation contained 
less than 2% surface immunoglobulin-positive  cells (SIg  +) and 97% of these cells formed rosettes 
with SRBC, i.e., E +. The lymphocyte fraction at the Ficoll-medium interphase of the second 
FHC was rerosetted with SRBC and subjected to a third FHC. Unrosetted cells at the Ficoll- 
medium interphase of this  last  separation were  referred  to as  B-enriched lymphocytes and 
contained 70-80% SIg  + cells and less than 2% E + cells. Fluorescent microscopy, using fluorescein 
isothiocyanate (FITC) conjugated rabbit anti-human-Fab  (Behring Diagnostics) was performed 
to identify SIg  + cells, i.e., B cells  (17). B cells were also enumerated by rosetting with SRBC 
coated with antibody (IgM) and complement (EAC)  (18). To enumerate lymphocytes forming 
rosettes with EAC, 0.5 ml of PBL (2 ×  10e/mi) was added to 0.5 ml of 0.5% EAC. This mixture 
was incubated for 30  rain at  37°C with agitation. The rosettes  formed were quantitated as 
above. B-enriched lymphocytes quantitated by this technique were 70-75%  EAC positive. 
Purified B iymphocytes were isolated utilizing rabbit anti-human-Fab  columns as described 
by Chess et al. (19, 20). In this procedure, isolated antibody to human Fab is linked to cyanogen 
bromide activated Sephadex G-200. The cells (200  ×  10") applied to this column were either 
PBL or B-enriched cells from the Ficoll-medium interphase after E-rosette sedimentation. In 
the case of PBL, unbound cells, consisting ofT (E  +) and N (SIg- and E-) cells are collected and 
bound cells eluted by competitive inhibition with human IgG (21). The bound-cell fraction 
contains 98% SIg  + cells and is referred to as B cells, while the unbound cells contain 82% E + 
cells and <  2% SIg  + cells. 
Isolation of N cells from PBL and B-enriched lymphocytes is described in the text. 
Cell Culture Conditions for Protein Synthesis in Human Lymphocytes.  Single cell  suspensions of 
PBL, T  cells,  B cells,  or N  cells  (10-50  ×  10  s)  were incubated in 3 ml of Eagle's minimal 
essential medium minus leucine (Grand Island Biological  Co.), without fetal calf serum, with 
10  #Ci  of [14C]leucine, sp  act  298  mCi/mmol, (New  England Nuclear,  Boston,  Mass.)  as 
previously described (12). The cells were incubated for 4 h at 37°C in a mixture of 95% air-5% 
CO2 in a humidified atmosphere (22, 23). After incubation, cell viability was determined with 
0.05% (vol/vol) trypan blue in PBS and only cultures with greater than 95% viability further 
utilized. The radiolabeled cells were then immersed in ice water, made 0.06 M in iodoacetamide, 
and centrifuged at 400 g for 10 min. The cells were washed in Eagle's complete medium four 
times at 4°C, resuspended in isotonic buffer (22), containing 0.5% Nonidet (NP-40) (Particle 
Data Lab. Ltd., Elmhurst, Ill.), 0.06 M iodoacetamide and 1,000 U/ml ofTrasyloi (Calbiochem, 
San Diego, Calif.). Detergent lysis was allowed to occur at 4°C for 20 min, and the resultant 
cell lysate centrifuged at  105,000 g for 30 min at 4°C, and the pellet discarded. 
Isolation of MICG  by  Cold Precipitation.  Cell  lysates  were  incubated for  2  days  at  4°C, 
centrifuged at 25,000 g for 20 rain, and the precipitate vigorously washed three times in cold 
PBS.  These conditions were found to be optimal for cold precipitation (12). The precipitate 
was solubilized for 30 rain at 37°C either in 2% (wt/vol) sodium dodecyl sulfate (SDS)-8  M 
urea-0.06 M iodoacetamide-Trasylol (1,000 U/ml)-0.1 M Tris buffer pH 9.2 (SDS-urea buffer) 
or in 0.5% Triton-X-100 (Amersham-Searle, Arlington Heights, Ill.)-2 M urea-0.1 M Tris buffer 
pH 8.2 (Triton-urea buffer). 
Preparation of Antisera.  New  Zealand white  rabbits were  used  to  raise  all  antisera  (12). 
Homogenous T-MICG, N-MICG, or a combination of T  and N-MICG was prepared by cold 
precipitation of isolated T and/or N-cell lysates. Homogeneity was assessed by SDS-polyacryl- 
amide gel electrophoresis (SDS-PAGE) and gel filtration on a  Biogel A-5M column (0.9 cm 
×  90 cm) equilibrated with 1% SDS-buffer (12). The isolated proteins used for immunization 
were solubilized in Triton-urea buffer. Antiserum to human IgM, IgA, IgG, albumin, transfer- 
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monospecific by immunoelectrophoresis and Ouchterlony analysis using normal human plasma 
and serum as antigen, as well as concentrated fractions of isolated serum proteins. In addition, 
specificity of antiserum was shown by radioimmunoassay  (1). All antisera were heat inactivated 
at 56°C for 30 rain before use. The antiserum  are referred to in the text as anti-T-MICG, i.e., 
antiserum  to T-cell derived MICG (T-MICG); anti-N-MICG, i.e., antiserum  to N-cell derived 
MICG  (N-MICG);  or  anti-CF  +  N)-MICG,  i.e.,  a  single  antiserum  to  both  T  and  N-cell- 
derived MICG. 
Radioiodination of Lymphocyte Lysates.  Cold precipitates of PBL lysates were deliberately not 
washed,  to  obtain  contamination  of the  cryoprecipitate  with  other  lymphocyte  associated 
proteins. The contaminated  precipitate was dissolved in 0.5% Triton-2 M  urea-Tris buffer pH 
8.1. The dissolved proteins were then radioiodinated with a2Sl (New England  Nuclear)  by the 
Chloramine T  method as previously described  (26,  27). An aliquot of this sample was directly 
electrophoresed or immune precipitated before SDS-PAGE. 
Immune Precipitation.  Radioiodinated samples were immune precipitated with antiserum  to 
MICG  (250/tl)  in  antibody  excess  and  incubated  at  37°C  for  16  h.  The  precipitates  were 
washed  three times in cold PBS, dissolved in SDS-urea buffer, and  incubated  at  37°C for 30 
min. In some experiments, radioiodinated lysates were precipitated with anti-T-MICG and the 
supernate  of this  precipitate  divided  into  two equal  aliquots.  One  portion  was  treated  with 
anti-T-MICG and the other with anti-N-MICG. In these experiments the first antiserum always 
depleted the protein to which it was directed. 
SDS-PAGE.  Solubilized cold and immune precipitates were reduced with 0.5 M  2-mercap- 
toethanol  for  1 h  at  37°C,  alkylated  with 0.65  M  iodoaeetamide,  and  then  dialyzed against 
0.01  M  phosphate  buffer pH  7.0,  0.1% with respect  to SDS  (0.1%  SDS buffer).  The samples 
were eleetrophoresed on 5% PAGE in 0.1% SDS for 31/2 h  at 8  ma per gel (28).  The gels were 
frozen at -70°C  and sliced into  1-mm sections and the radioactivity eluted overnight at 37°C 
in 0.1% SDS-buffer. 5  ml of Aquasol (New England  Nuclear)  was added  after the over night 
incubation and the samples counted in a  liquid scintillation spectrometer. Marker proteins for 
molecular weight determination of samples were simultaneously electrophoresed on companion 
gels and  stained  (12).  Alternatively, IgM and  IgG were isolated  by immune  precipitation  of 
[14C]leucine  labeled  mouse  plasmacytoma  cells  of  the  appropriate  class.  The  radiolabeled 
markers were reduced and electrophoresed on companion gels, which were sliced and counted 
(12).  Intracellular  8  S  IgM  (200,000  dahons)  was  immunoprecipitated  from  MOPC  104E- 
labeled  lysates  and  electrophoresed  in  the  unreduced  state.  Standard  curves  for  molecular 
weight were constructed for each electrophoretic run and the values given are means of at least 
three separate determinations. 
Cytotoxicity.  Lymphocyte cell suspensions  were washed  in McCoy's medium  (Grand  Island 
Biological Co.) and cytotoxicity measured in microtiter plates employing eosin dye incorpora- 
tion to determine cell death  (29,  30). To 2,000 cells in  1 bd of McCoy's medium containing 5% 
fetal calf serum  was  added  1 /.d of rabbit  antiserum  or normal  rabbit  serum.  The cells were 
incubated at room temperature  for 30 min and then 5 pl of rabbit  complement  (Grand Island 
Biological Co.) was added to each well and incubation continued for 2 h at room temperature. 
Eosin dye was added and each well scored for the number of cells incorporating dye (cell death) 
in the following manner:  1 =  0-10%;  2  --  11-20%;  3  =  21-30%; 4  =  31-50%;  5  =  51-70%; 
6  =  71-80%;  7  =  81-90%;  and  8  >91%.  Controls  in  these experiments consisted of normal 
rabbit  serum  and  rabbit  anti-human  albumin  antiserum,  or medium.  These sera  showed  no 
cytotoxicity in the presence or absence of rabbit complement. The rabbit  complement did not 
induce cell death when incubated with lymphocytes in the absence of antiserum. 
Immunofluorescence of Lymphocyte Plasma Membrane.  Indirect  immunofluorescence  was  per- 
formed on viable PBL and subpopulations obtained from anti-Fab columns (31,  32).  Lympho- 
cytes  (2  ×  10  n)  were  incubated  for  1 h  at  37°C  in  3  ml  Eagle's minimal  essential  medium 
supplemented  with  20%  fetal  calf serum  and  0.2%  sodium  azide.  The  cells  were  washed, 
resuspended  in 0.1  ml of medium, and  incubated at 4°C for 30 min with 0.1  ml of anti-(T  + 
N)-MICG antiserum  (1:64). The antiserum employed was the IgG fraction, heat inactivated at 
56°C and adsorbed with calf liver powder before use. In some experiments the rabbit  IgG was 
digested with pepsin to produce an Fab2 T-fragment, as previously shown (33). The cells were 
washed  three  times  in  medium,  resuspended  in  0.1  ml  of medium,  and  0.1  ml  of  FITC 
conjugated goat anti-rabbit IgG (Behring Diagnostics)  (1:32) added. Incubation was continued HAUPTMAN, KANSU, SERNO, AND GODFREY  161 
for 30 min at 4°C, the cells washed three times, and finally resuspended  in 0.1 ml of medium. 
A drop of the cell suspension was applied  to a microscope slide with the bottom of a  12 x  75 
mm test tube, fixed in ethanol (95%) and a cover slip applied in buffered glycerol (34). 
Direct  immunofluorescence  was  also  performed  on  viable  lymphocytes  utilizing  FITC 
conjugated rabbit anti-human-Fab antiserum  (Behring Diagnostics). Lymphocytes, 2 X  106/0.1 
ml  of medium, were  incubated with  a  1:16 dilution of antiserum  for  30 rain  at  4°C  and 
processed as in the indirect  technique. 
The preparations  were examined  with  a  Zeiss IV FL-epifluorescent  microscope equipped 
with an Osram 12 V, 100 W, halogen lamp and an incident-light  fluorescence illuminator.  The 
following combination of exciting  and  barrier  filters and  of beam splitters  were  used:  for 
visualization  of fluorescein, exciting filter 450-490 nm, barrier filter LP 520, beam splitter  FT 
510. The same field of cells was also examined by phase contrast microscopy. Photographs were 
recorded on Ektachrome ASA 200 film. Indirect specificity controls consisted of normal rabbit 
serum, in place of anti-(T +  N)-MICG, and absorption  experiments.  Less than  1% PBL were 
immunofluorescent  positive at  1:2 dilution  of normal rabbit IgG (1 mg/ml). Indirect fluores- 
cence was completely blocked by absorption of anti-(T +  N)-MICG with either PBL, T  +  N 
cells (300 X  10e/0.5 ml of antibody)  or T  +  N-MICG antigen (45 #g). Indirect immunofluo- 
rescence was also blocked by adsorption  of FITC goat anti-rabbit IgG with rabbit IgG. There 
was no inhibition  of immunofluorescence  when anti-(T +  N)-MICG antiserum  was adsorbed 
with lyophilized human plasma (20 mg/ml), normal B cells, or chronic lymphocytic leukemia 
cells at cell concentrations  of 300 X  106/0.5  ml of antibody. 
Results 
Isolation and Characterization of MICG Proteins  from Human Lymphocytes.  When radio- 
labeled  lysates  from  PBL  were  cold  precipitated,  SDS-PAGE  demonstrated  two 
macromolecules with mol wt of 225,000 and  185,000  daltons, accounting for 90 and 
10%, respectively, of the cryoprecipitate (Fig.  1 a). Incubation of cell lysates for 48 h 
at  22°C  did  not  induce  the  precipitation  of MICG-like proteins.  Similar to mouse 
MICG, both  macromolecules had  the  electrophoretic  mobility of fl-globulins  (12). 
Cryoprecipitate analyzed by SDS-PAGE, and stained for protein with Coomasie Blue 
is shown in Fig. 2 a. Using suitable standards, the mol wt of the two major proteins 
were  calculated  to  be  225,000  and  185,000  daltons,  similar  to  the  radiolabeled 
preparations.  Although  a  small  amount  of contamination  is  present  in  this  gel,  a 
homogenous protein can be obtained by thorough washing of the cold precipitate. 
Analysis  of cold  precipitates  from  T  and  B-enriched  cells,  isolated  by  rosette 
sedimentation, showed that the T lymphocytes synthesized the 225,000 dalton protein, 
while the B-enriched cells synthesized the 185,000 dalton macromoleeule (Figs.  1 b, 1 c 
and  2b,  2c).  In  four separate  experiments  with  different  histocompatability typed 
lymphocytes, neither cell population synthesized the two proteins simultaneously. To 
investigate whether some form of interaction between T  and B cells might influence 
the relative quantity of the two proteins synthesized, varying numbers of T  cells were 
added to a  constant number of B cells  before incubation with [14C]leucine.  SDS gels 
of the cryoprecipitates from this experiment demonstrated that the amount of either 
the  225,000  or  185,000  dalton  protein  was  similar  to  that  obtained  from  equal 
numbers of isolated T  or B cells. 
Further Purification  of B  Lymphocytes.  The  B-cell  enriched  fraction,  obtained  by 
double rosette sedimentation depletion of T  cells, contained 70-80% SIg  + cells,  3-7% 
monocytes, and  10-15%  iymphocytes which  were  E-  and  SIg-. To obtain  a  more 
homogeneous population of B-lymphocytes, PBL were separated into subpopulations 
by fractionation on anti-human-Fab Sephadex  G-200 columns.  Utilizing this  tech- 
nique along with monocyte depletion by adherence to plastic Petri  dishes, 98%  SIg  + 162  CELL ORIGIN OF MACROMOLECULAR  INSOLUBLE  COLD GLOBULIN 
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Fio.  1.  Cold precipitation of radiolabeled ([~4C]leucine) human MICG proteins from lysates of: a, 
PBL (36 ×  106 cells); b, T cells (12 ×  10  n cells); c, B cells (12 ×  106). Precipitates were reduced and 
subjected to SDS-PAGE (5%). Arrows indicate the position of labeled markers. Top of the gel is on 
the left hand side of figure. ~, IgM heavy chains; "y, IgG heavy chains; L, light chains. 
cells were obtained. Cold precipitated lysates from the unbound  cell fraction  (T and 
N)  synthesized both  the 225,000  and  the  185,000  dalton  macromolecules  (Fig. 3a), 
while  equal  numbers  of viable  B  lymphocytes  from  the  anti-Fab  column  did  not 
synthesize  either  protein  (Fig.  3b).  To  be  certain  that  these  B  lymphocytes  were 
capable of protein synthesis, radiolabeled lysates were shown to synthesize IgM when 
analyzed on SDS-PAGE (not shown). 
Although  the T  cells obtained  by the anti-Fab columns contain  80-85%  E + cells 
and  less than  2%  SIg  ÷ cells, there  is a  substantial  number  of cells that  are E-  and 
SIg-, referred to as N  cells (21).  To establish whether the  185,000  dalton macromol- 
ecule  was  the  product  of this  N-cell population,  unbound  cells from  the  anti-Fab 
column were rosetted with SRBC and subjected to FHC. The radiolabeled lympho- 
cytes from the SRBC pellet (98% E ÷)  were lysed, cold precipitated, and subjected to 
SDS-PAGE. These T  cells again demonstrated the 225,000  dalton component, while 
the N  cells, at the Ficoll-medium interphase, synthesized the  185,000  dalton protein 
(Fig. 4a and 4b). The N  cells consisted of less than 2% E + cells and less than  1% SIg  + 
lymphocytes. 
Further  proof of  the  N-cell  origin  of  the  smaller  protein  was  obtained  in  the HAUPTMAN, KANSU,  SERNO,  AND GODFREY  163 
FIG.  2.  Cold precipitation of human MICG protein from lysates of: a, PBL (300 ×  10~); b, T cells 
(75  ×  106); c, B cells (75  ×  106). Precipitates were reduced and subjected to 5% SDS-PAGE and 
stained with 0.5% Coomassie Blue. 
following experiment.  PBL were subjectocl to double rosette sedimentation with SRBC 
to deplete  the T-cells.  An aliquot  of the Ficoll-medium  interphase  cells was radiola- 
beled  and the remainder  applied  to anti-human-Fab  columns.  Bound and  unbound 
cells were  also radiolabeled  and  all  lysates cold precipitated  and  analyzed on  SDS- 
PAGE.  The  interphase  cells,  i.e.,  B  enriched  cells,  demonstrated  a  single  peak  of 
radioactivity of 185,000 daltons. The unbound, N cells, synthesized a radioactive peak 
of the same mobility, while no cold insoluble radioactive peak was found in the eluted 
B-cell  fraction.  The  N  cells were less than  2%  SIg  ÷ and  less  than  1%  E ÷. These  two 
proteins are referred to as T-MICG (225,000 daltons) and N-MICG (185,000 daltons). 
The same sequence  of experiments,  performed  on  lymphocytes obtained  from three 
other individuals, yielded identical results  to those above. 
Immunological Analysis of Human Ctyoproteins.  On immunoelectrophoresis  anti-Cr  + 
N)-MICG antiserum  showed two precipitan  arcs of/~-mobility against  PBL lysates, 
but did not react with whole human plasma or serum. This antiserum  showed single 
precipitan arcs against purified T-MICG and purified N-MICG. Similar results were 
obtained  in  Ouchterlony  analysis.  Antiserum  to  purified  T-MICG  gave  a  single 164  CELL  ORIGIN  OF  MACROMOLECULAR  INSOLUBLE  COLD  GLOBULIN 
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Fzo.  3.  Cold  precipitation  of radiolabeled  lysates derived  from T  and  B  cells, isolated by  anti- 
human-Fab columns.  PBL were subjected to an anti-human-Fab column and unbound  (T and N) 
cells; a, and eluted (B)  ceils; b, (22  X  10  s cells) labeled with [z4C]leucine. Cold precipitates were 
reduced and subjected to SDS-PAGE (5%). 
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FIG.  4.  Rosette sedimentation on FHC of the unbound cell fraction from anti-human-Fab column. 
PBL were subjected to anti-human Fab columns and the unbound fraction incubated with SRBC 
and  rosette  sedimented  by  FHC.  a,  SRBC  pellet  (T  cells)  was  hypotonically  ]ysed  and  the 
lymphocytes (30 X  106) radiolabeled with [t4Clleucine. b, Ficoll-medium interphase cells (null cells) 
(30  ×  10  e)  were also radiotabeled  with [14C]leucine.  Radiolabeled  lysates were cold precipitated, 
reduced, and subjected to 5% SDS-PAGE. HAUPTMAN, KANSU, SERNO, AND GODFREY  165 
precipitan line against  purified T-MICG, but did not react with purified N-MICG. 
With anti-N-MICG antiserum, there was a single precipitan line against purified N- 
MICG,  but  no  reaction with  purified T-MICG.  When  each of these  antisera  was 
reacted with (T  +  N)-MICG, only one or the other of the two precipitan lines seen 
with anti-(T +  N)-MICG developed. Rabbit anti-whole human serum did not react 
with isolated T-MICG or N-MICG, nor did antisera to human IgG, IgA, IgM, IgD, 
IgE, a2 macroglobulin, transferrin, albumin, or cold insoluble globulin. 
When  an  unwashed  cold precipitate  from  PBL  is  subjected  to  SDS-PAGE  and 
stained for protein, a number of bands are seen, in addition to T-MICG and N-MICG 
(not shown). In contrast, thorough washing of the cold precipitate, before dissolving 
for SDS-PAGE, reveals only two bands (Fig. 2 a). The other protein bands, deliberately 
produced by incomplete washing of the cryoprecipitate, would serve as a control for 
determining the specificity of the antisera. Accordingly, unwashed precipitates from 
PBL were  dissolved  in  Triton-urea and  radioiodinated.  The  radiolabeled  proteins 
were immune precipitated with one antiserum and the supernate tested for reactivity 
with a second antiserum. The precipitates were analyzed on SDS-PAGE. The results 
in Fig. 5 demonstrate that antiserum to T-MICG only precipitated the larger (225,000 
dahons)  of these two proteins  (Fig.  5a),  while antiserum  to N-MICG only reacted 
with  the smaller  (185,000  dahons)  protein  (Fig.  5b).  Furthermore, anti-(T  +  N)- 
MICG antiserum precipitated both of these components from the radiolabeled lysates 
(Fig.  5c).  In  these studies, the first antiserum  totally depleted the supernate of the 
component  to which  it  was  reactive.  Normal  rabbit  serum  had  no effect on  these 
radioiodinated proteins (Fig. 5 c). 
Cytotoxicity Induced by Antiserum to MICG.  The expression of these antigens on the 
cell surface was examined by means of antibody induced cytotoxicity. In the experi- 
ments shown in Fig. 6, PBL, or cells fractionated on anti-Fab columns were reacted 
with dilutions of antiserum in the presence of complement. Anti-T-MICG antiserum, 
to a titer of 1:256, induced 80% cytotoxicity of PBL, while anti-N-MICG and normal 
rabbit serum were not cytotoxic to PBL, beyond a  titer of 1:4. When unbound cells 
(T +  N), from anti-Fab column fractionated PBL, were treated with anti-or  +  N)- 
MICG antiserum, to a titer of 1:128, 98% of the cells were killed (Fig. 6). In contrast, 
anti-CI"  +  N)-MICG was not cytotoxic, beyond  1:2, to B cells eluted from the anti- 
Fab column. 
Cell Surface Distribution of MICG.  Immunofluorescent  studies  employing anti-or 
+  N)-MICG antibody revealed that 85-88% of PBL displayed a  ringed fluorescent 
pattern (Fig. 7). If the first antibody in indirect immunofluorescence was rabbit anti- 
human IgM,  12% of PBL were positively stained. Similar numbers of SIg  + cells were 
found with the direct technique. It was also shown that the Fab2 T-fragment of anti- 
(T  +  N)-MICG  antibody  stained  85%  of PBL  in  a  ringed  fluorescent  pattern. 
Furthermore, anti-T-MICG antiserum stained  78-80% of PBL. The anti-(T  +  N)- 
MICG pattern was completely inhibited by absorption with the unbound cell fraction 
(T  +  N)  from an anti-Fab column, as well as by isolated T  and  N-MICG antigen. 
There was  no  loss  of immunofluorescence when  the  antibody was  adsorbed  with 
purified B cells, or lyophilized human  plasma.  Further evidence for the absence of 
either T  or N-MICG antigen from the surface of B cells was provided using anti-Fab 
column purified lymphocytes. The unbound  fraction demonstrated uniform ringed 
fluorescence (98-100%) with anti-C  I" +  N)-MICG antibody, while only 1-2% of these 166  CELL  ORIGIN  OF  MACROMOLECULAR  INSOLUBLE  COLD  GLOBULIN 
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Fro.  5.  Antigenic properties  of  human  T-MICG  and  N-MICG.  Cryoprotein  (unwashed)  from 
PBL  lysates was dissolved in 0.5% Triton-X-100-2  M  urea and  radioiodinated. The  proteins were 
immune  precipitated  at  37°C  with  anti-T-MICG  or  anti-N-MICG  antiserum  and  the  supernate 
treated with the second antiserum.  All samples were reduced  and  applied to  SDS-PAGE  (5~).  a, 
Precipitated  with  anti-T-MICG  (  )  and  the  supernate  treated  with  anti-N-MICG  (  ..... );  b, 
Precipitated  with  anti-N-MICG  (  )  and  the  supernate  reacted  with  anti-T-MICG  (  ..... ):  c, 
Reacted  with  normal  rabbit  serum  (  ..... )  and  the  supernate  reacted  with  anti-(T  +  N)-MICG 
antiserum (  ). @ 
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RECIPROCAL  OF  ANTISERUM  DILUTION 
Fro.  6.  Cytotoxicity of human lymphocytes treated with antisera to M|CG  proteins. PBL, T  +  N 
cells, and B cells were treated with dilutions of antiserum and complement and cell death determined 
by eosin dye incorporation. NRS, normal rabbit serum. 
Fzc.  7.  Plasma membrane distribution  of MICG  determined  by  indirect  immunofluorescence. 
PBL were reacted with rabbit  anti-human-(T +  N)-MICG antibody for 30 min at 4°C. The cells 
were washed and treated  with FITC conjugated goat anti-rabbit  Ig antibody for 30 rain at 4°C. 
After washing, a drop of  cell suspension was fixed on slides and examined under a Zeiss epifluorescent 
microscope with selective filters. 
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cells were stained with FITC conjugated anti-IgM antibody. The bound fraction had 
4% fluorescent-positive cells with anti-(T  +  N)-MICG antibody, while 97% of these 
cells were SIg  +. 
Discussion 
This paper details observations of a human protein, MICG, which is synthesized in 
human T  cells. The name T-MICG was derived from its major biochemical charac- 
teristics: the protein is a macromoleeule with a tool wt of 225,000 daltons, is insoluble 
in the cold in nonionic detergents, has the mobility of a fl-globulin on electrophoresis 
and is synthesized by T  cells. We have previously applied the term MICG to a similar 
protein found in mouse T  cells (12,  13). Preliminary evidence suggests cross-reactivity 
between T-MICG from mouse and human lymphocytes. We have further described 
another macromolecule, N-MICG, which has a mol wt of 185,000 dahons, appears to 
be antigenically  distinct  from T-MICG and  is synthesized in N  Cells.  The term N- 
MICG has been employed, because the physicochemical properties of this protein are 
similar to T-MICG. 
Evidence  for the divergent cell  origin of these  two proteins was provided by cell 
separation techniques utilizing E rosette sedimentation. This revealed that the T  cells 
synthesized the  225,000  dalton  protein, while the B-enriched  fraction produced  the 
185,000 dalton macromolecule. Analysis of cell homogeneity revealed that the T  cells 
were 97% E +, while the B-enriched cells contained  75%  SIg  + cells. When the B cells 
obtained  by rosette sedimentation  were  applied  to  anti-Fab  columns,  the  185,000 
dalton protein was found to be a  product of the N  cells and not the B lymphocytes. 
In these latter cell preparations, the B ceils were 98% SIg  ÷, while the N cells contained 
less than 2% SIg  + cells and less than  1% E + cells (SIg-, E-). Furthermore, when PBL 
were applied directly to anti-Fab columns, neither form of MICG was synthesized in 
the eluted B cells. In contrast, the unbound ceils, containing T  and N cells, synthesized 
the two components. When this latter cell fraction was rosette sedimented the 225,000 
dalton component was synthesized in the T  cells and the  185,000 dalton component 
synthesized in the N-cell fraction. 
Although the cell of origin ofT and N-MICG differed, it remained to be determined 
whether  these  proteins  were  antigenically  dissimilar.  The  evidence  obtained  by 
Ouchterlony  analysis  suggested,  but  did  not  prove,  antigenic  diversity.  Further 
support  of their  antigenic  uniqueness  was  established  by  utilizing  radioiodinated, 
partially purified T  and  N-MICG. These experiments showed that antiserum to T- 
MICG  precipitated  the  larger  macromolecule  (225,000  dalton),  while  the  smaller 
(185,000  dalton)  component  remained  in  the  supernatant.  On  the  other  hand, 
antiserum to N-MICG precipitated  the smaller component, while the larger protein 
remained  in  the  supernatant.  During  early  studies  with  human  MICG,  we  were 
unable to resolubilize the cryoproteins in aqueous buffers, including those containing 
6 M  quanidine or 8 M  urea, regardless of reduction  and alkylation. MICG was also 
not completely soluble in either NP-40 or Triton X-100 at concentrations from 0.1% 
to 5%  (vol/vol), i.e., only 30% of the cryoprotein was soluble in 0.5% Triton X-100. 
The marked insolubility of these proteins in cold solutions necessitated resolubilization 
in 0.01% SDS or 0.5% Triton-2 M  urea in which  100% of the cryoprotein was soluble. 
Furthermore, partially purified preparations were used and therefore monospecificity 
of antiserum  could  not  be  completely  established.  However,  recent  experiments, HAUPTMAN,  KANSU,  SERNO,  AND  GODFREY  169 
addressing this question,  have clearly demonstrated  the antigenic dissimilarity of T 
and N-MICG. 
Studies employing antibody induced cytotoxicity suggested the presence of T  and 
N-MICG on  the lymphocyte plasma membrane. Cytotoxicity experiments utilizing 
anti-T-MICG  antiserum  demonstrated  that  T-MICG was  present  on  the  plasma 
membrane of 80% of PBL. The lack of effect on antiserum to N-MICG on PBL may 
have been due to the small number of N cells, i.e., 4-10% in PBL. In immunofluores- 
cent experiments, to be separately reported, we have shown that N-MICG is present 
on the plasma membrane of 4-7% of PBL, which are E- and SIg-.  2 When cytotoxicity 
of T  and  N  cells was induced  by anti-(T  +  N)-MICG the percent  killed cells was 
98%, compared to 80% for PBL. This difference can be accounted for by the absence 
of B cells in the T  and N-cell fraction. Furthermore, this antiserum was not cytotoxic 
to B cells. 
Direct evidence of the plasma membrane nature of these antigens was provided by 
immunofluorescence examination. These studies clearly showed that T, and probably 
N-MICG, were located on the plasma membrane of T  and N  cells, respectively, but 
not on B-cells. In addition, we have shown that T-MICG can be capped by incubation 
of PBL with anti-T-MICG antiserum for 30 min at 37°C. Although these experiments 
suggest  that  neither T-MICG nor N-MICG are found on most B lymphocytes, it is 
possible that one of these proteins is present on a small subpopulation of B cells. The 
B-cell fraction from the anti-Fab column did contain 4% MICG-positive cells. We are 
currently examining PBL by combined immunofluorescence with  FITC conjugated 
anti-N-MICG antiserum and rhodamine conjugated anti-Ig antiserum to determine 
whether a subpopulation of B-cells has both N-MICG and Ig on their surface. 
In the mouse, T  lymphocytes can be clearly distinguished  from other lymphocyte 
subpopulations by virtue of a  number of well defined surface markers (5-7).  Mouse 
T  cells have Thy  1.2  antigen  and  Ly antigens.  B  cells in  both man and  mouse are 
typified by cell surface immunoglobulin  (1-4).  In contrast,  human T  cells have few 
well  characterized  surface antigens.  The  SRBC  rosette  receptor has  partially  been 
characterized,  while  the  HTLA antigen  has  been  defined  by serological  methods 
(8-10). Our results suggest that human T  cells can be distinguished  by virtue of the 
presence of a  new antigenic marker, i.e., T-MICG. Furthermore, N  cells, defined as 
E-, SIg-, can also be characterized by virtue of another protein, N-MICG. Although 
a  fraction  of N  cells  in  man  display  the  B-cell  antigen  (equivalent  to  mouse  Ia, 
immune response associated antigen),  this  antigen  is also  found  on  B  lymphocytes 
(35-39).  In contrast, N-MICG is not found on either T  or B-cell populations. 
Further  studies  are  in  progress  in  our  laboratory  to  determine  the  biological 
significance of these proteins. 
Summary 
Although  surface  immunoglobulin  characterizes  B  cells  in  man,  there  are  few 
surface markers that distinguish T  cells. We have described a new protein synthesized 
in  human  T  cells,  termed  T-MICG.  This  protein  is  a  macromolecule of 225,000 
dahons,  is  insoluble  in  the  cold,  and  migrates  as  a  /~-globulin  on  electrophoresis. 
Separation of human peripheral blood lymphocytes into T  and B-cell populations by 
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rosette sedimentation and anti-human-Fab columns clearly demonstrated  the T-cell 
origin  of  the  225,000  dalton  component.  Furthermore,  null  cells  were  shown  to 
synthesize a  protein of  185,000  daltons,  termed  N-MICG,  with  physical properties 
similar to T-MICG. T-MICG and N-MICG were shown to be antigenically dissimilar, 
employing antiserum to each of these proteins. The present studies demonstrate two 
novel cell surface  markers,  T-MICG  and  N-MICG,  which  characterize T  cells and 
null cells, respectively. 
Received for publication  14 August  1978. 
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